Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas

British Journal of Haematology

Volumn 145, Issue 2, 2009, Pages 255-257

  Mazzaro, Cesare ^a,b   De Re, Valli ^a   Spina, Michele ^a   Dal Maso, Luigino ^a   Festini, Gianluca ^c   Comar, Consuelo ^c   Tirelli, Umberto ^a   Pozzato, Gabriele ^c  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Pordenone General Hospital   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Chronic hepatitis C; Hepatitis C virus; Interferon; Non Hodgkin's lymphoma; Ribavirin

Indexed keywords

ALPHA2B INTERFERON; CRYOGLOBULIN; HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON ALPHA2B; RHEUMATOID FACTOR; RIBAVIRIN; VIRUS RNA;

ANEMIA; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DOSE RESPONSE; DRUG DOSE REDUCTION; FOLLICULAR LYMPHOMA; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMED CONSENT; LETTER; LIVER BIOPSY; LYMPHOPLASMACYTOID LYMPHOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PATIENT COMPLIANCE; PATIENT SELECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLEEN LYMPHOMA; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; LYMPHOMA, NON-HODGKIN; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 63149193476     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07565.x     Document Type: Letter

References (9)

1. Gisbert, J.P., García-Buey, L., Pajares, J.M. Moreno-Otero, R. (2005) Regression of lymphoproliferative disorders after treatment for hepatitis C infection. Alimentary Pharmacology & Therapeutics, 15, 653 662.
2. Hermine, O., Lefrère, F., Bronowicki, J.P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., Varet, B. Troussard, X. (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. New England Journal of Medicine, 347, 89 94.
3. Manns, M.P., McHutchinson, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M. Albrecht, J.K. (2001) PEG-interferon alfa-2b in combination with ribavirin compared to interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C. Lancet, 358, 958 965.
4. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.G., Houghton, M., Rosa, D., Grandi, G. Abrignani, S. (1998) Binding of hepatitis C virus to CD81. Science, 282, 938 941.
5. Pozzato, G., Mazzaro, C., Crovatto, M., Modolo, M.L., Ceselli, S., Mazzi, G., Sulfaro, S., Franzin, F., Tulissi, P., Moretti, M. Santini, G.F. (1994) Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood, 84, 3047 3053.
6. Pozzato, G., Mazzaro, C., Franzin, F., Tulissi, P., Pussini, E., Crovatto, M., Carniello, G.S., Efremov, D.G., Burrone, O. Santini, G. (1996) Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer, 77, 2604 2613.
7. Rosa, D., Saletti, G., De Gregorio, E., Zorat, F., Comar, C., D'Oro, U., Nuti, S., Houghton, M., Barnaba, V., Pozzato, G. Abrignani, S. (2005) Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proceedings of the National Academy of Sciences of the United States of America, 102, 18544 18549.
8. Vallisa, D., Bernuzzi, P., Arcaini, L., Sacchi, S., Callea, V., Marasca, R., Lazzaro, A., Trabacchi, E., Anselmi, E., Arcari, A.L., Moroni, C., Bertè, R., Lazzarino, M. Cavanna, L. (2005) A Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. Journal of Clinical Oncology, 23, 468 473.
9. Zignego, A.L., Ferri, C., Giannelli, F., Giannini, C., Caini, P., Monti, M., Marrocchi, M.E., Di Pietro, E., La Villa, G., Laffi, G. Gentilini, P. (2002) Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Annals of Internal Medicine, 137, 571 580.